
account no longer monitored. find me on Bluesky @Eomesodermin.bsky.social
Bonn, Germany
Joined October 2014
- Tweets2.2K
- Following1.8K
- Followers596
- Likes2K
🚨 Open #position! The group of Zeinab Abdullah is looking for a Technical Assistant/Research Assistant
Application deadline: October 30 immunosensation.de/opportuni…
1,601
🚨 Open #position! The group of Zeinab Abdullah is looking for a postdoc
Application deadline: October 30 immunosensation.de/opportuni…
1,591
🚨 Open #position! The group of Zeinab Abdullah is looking for two PhD students for
a) Characterisation of hepatic NK-like T cells
b) Dissecting the role of STING signalling in anti-viral T cell responses
Application deadline: October 30 immunosensation.de/opportuni…
1
1,511
My twitter/X feed has like many others become filled with Elon and Trump/Trump adjacent nonsense. I’m giving BlueSky a go and so far looks like a good portion of scitwitter has begun the migration. Come find me on the other app and let’s talk science.
74
I am excited to share our latest paper. We profiled CD8+ TILs from HPV- HNSCC patients using scRNA/TCRseq. In addition, we performed an ex vivo stimulation of cells to capture their transcriptional response. 1/n
onlinelibrary.wiley.com/doi/…
1
3
230
This paper scratches the surface of understanding how prolonged/sustained IFN impacts CD8+ TILs. We found it interesting that these cells can be observed in many scRNAseq datasets but are rarely mentioned. We hope this manuscript inspires others look further at these cells. 6/n
1
1
59
As always, many thanks to the patients and many collaborators. @Doc_Bald @IEO_baldlab @IEO_Bonn @theHumanBorch
37
Dillon Corvino retweeted
Following several kind requests, here is a high-level summary of our pre-print in @biorxivpreprint (doi: doi.org/10.1101/2024.10.03.6…):
STAMP: Single-Cell Transcriptomics Analysis and Multimodal Profiling through Imaging
STAMP is a scalable, cost-efficient method for single-cell transcriptomics and multimodal profiling through imaging. It bypasses sequencing, significantly reducing costs while enhancing throughput.
#SingleCellRNA #SpatialOmics #STAMP
The motivation for this paper comes from the limitations of current scRNA-seq methods, which are costly, inefficient, and struggle to capture low- and high-abundance transcripts. Challenges like droplet instability, cell damage, limited cell capture, cross-contamination, inefficient indexing, and high sequencing costs affect ultra-low and ultra-high cell profiling, hindering accurate analysis of complex cell populations. #Limitations #DropletMicrofluidics
STAMP addresses these issues with a scalable, cost-effective, sequencing(costs)-free approach that works efficiently across ultra-low to ultra-high cell numbers, while preserving cellular morphology and enabling multimodal profiling. #SpatialOmics #UltraLow #UltraHigh
STAMP uses an imaging-based approach to perform high-throughput RNA and protein profiling by stamping cells onto slides compatible with CosMx and Xenium platforms, allowing multimodal profiling in a single run.
#Proteomics
STAMP supports single-modal (RNA/protein) and multimodal (RNA + protein) profiling, enhancing experimental flexibility and scalability. This versatility is essential for large-scale atlases and mixed-sample experiments.
#SingleCellAtlas #MultiSampleProfiling
STAMP scales easily: from less than 100 to millions of cells. It overcomes limitations in droplet-based systems, where throughput is often constrained by sequencing costs.
#HighThroughput
STAMP handles diverse sample types: PBMCs, dissociated tumors, nuclei, and stem cells. It also excels with fragile or archived tissues, where traditional methods often fail to yield high-quality data.
#ArchivedSamples
STAMP eliminates sequencing costs, making large-scale single-cell analysis accessible to more labs. #CostEfficiency
Here’s a cost comparison between GEM-X and STAMP-X for RNA profiling:
GEM-X RNA (20k cells): $0.0764/cell
1M cells = $76,400 (cost/cell = $0.0764)
2M cells = $152.800 (cost/cell = $0.0764)
3M cells = $229,200 (cost/cell = $0.0764)
STAMP-X RNA (1M cells): $0.0075/cell
1M cells = $7,500 (cost/cell = $0.0075)
2M cells = $7,500 (cost/cell = $0.00375)
3M cells = $7,500 (cost/cell = $0.0025)
In STAMP cells remain intact after imaging, enabling further downstream applications like histological validation or additional molecular assays, adding value to each sample.
#NonDestructiveAnalysis
We tested STAMP’s sensitivity by identifying, ultra-rare, circulating tumor cells (CTCs) spiked into PBMCs at 1:100,000. Such sensitivity is essential for clinical diagnostics, particularly in rare cell detection.
#CTCs #CancerDiagnostics
In a high-throughput immuno-phenotyping experiment, STAMP profiled 1.7M PBMCs, capturing a median of 83 transcripts and 49 genes per cell. This resulted in high-resolution immune profiling.
#Immunology #HighThroughputProfiling
31 immune cell states were mapped in PBMCs, capturing rare subpopulations (Th1/Th2/Th17 and NK subtypes). Detailed immune phenotyping is critical for understanding immune diversity in health and disease.
#ImmuneMapping
Whole cells vs. nuclei: STAMP's ability to profile both whole cells and nuclei is crucial for samples with low RNA content (e.g., archived tissues), increasing the platform’s applicability.
#NucleiProfiling #SingleCellOmics
STAMP integrates RNA and protein profiling. In cancer cell line profiling, RNA and protein data showed strong correlations, confirming the platform’s robustness in multimodal data collection.
#MultimodalProfiling
STAMP’s multimodal profiling produced high-resolution immune maps, combining RNA and protein data. This approach is essential for dissecting complex immune states and understanding functional responses.
STAMP excels in low-input samples. We demonstrated its ability to accurately profile as few as 100 cells, which is critical for studying rare populations in small samples.
#LowInput #RareCell
In a BMP4-driven stem cell differentiation model, STAMP captured dynamic changes from pluripotency to mesoderm and endoderm progenitors over multiple timepoints, tracking lineage differentiation.
#StemCellDifferentiation #LineageTracing
Trajectory analysis shows that STAMP’s resolution makes it a powerful tool for developmental biology and perturbation studies.
#DevelopmentalBiology #hESC
STAMP allows multi-sample profiling on a single slide, reducing batch effects and improving comparative analysis, particularly in drug response and perturbation studies.
#MultiSampleAnalysis #PerturbationScreening
STAMP represents a significant advance in single-cell research, offering scalable, multimodal RNA/protein profiling at low cost. Its versatility will support a broad range of research, from basic to clinical.
#SingleCellTechnology
Lots more coming soon...
@DrJasPlummer @hoheyn @pascual_reguant @EmanuelePitino1 @helucro @ximbaozao @irepan_salvador @Kellieiswise @m_mohenska @jc_nietos @cnag_eu @StJudeResearch @ACEpigenetics @M_ayco_N @eliseinsing Bill Flynn, Yutian Liu, Hannah Chasteen
Dillon Corvino retweeted
Online now: T lymphocyte recruitment to melanoma brain tumors depends on distinct venous vessels dlvr.it/TF0Kg6
Dillon Corvino retweeted
We are looking for a highly motivated PhD Student! 🤩
If you are passionate about science and interested in tumor immunology and metabolism… join us in Bonn! 👩🏻🔬👨🔬
please share🙏
Dillon Corvino retweeted
We developed an imaging-free spatial genomics technology where DNA barcodes diffuse to connect locally. Using UMAP, we reconstructed the physical locations of these barcodes, transforming spatial transcriptomics into purely molecular biology.
biorxiv.org/content/10.1101/…
Dillon Corvino retweeted
🚨New lab preprint! 🚨
A deep dive to shed light on a long-standing controversy with RNA-targeting CRISPRs: Do they have high levels of collateral (trans) cleavage of other RNAs in the cell ✂️✂️✂️ — or not?
New work from talented PhD student #SydneyHart & others in our lab. 📰
Dillon Corvino retweeted
Rikard Forlin from @BrodinPetter lab presents results of our collaboration with @PixelgenTech at #HumanImmun24
Cool technology btw😉
Dillon Corvino retweeted
This represents how we believe haematopoiesis is actually proceeding at a clonal level. I'll walk through our preprint early next week. "A multi-track landscape of haematopoiesis informed by cellular barcoding and agent-based modelling" biorxiv.org/content/10.1101/…
Dillon Corvino retweeted
Very excited (& nervous) to share what we've been working on the past many years. Only took 3 first authors (Schreuder the experimentalist, @DawnSLin the analyst, and @syzmath the modeller) & co-senior Weber (computational, modeller, SynBio extraordinaire) biorxiv.org/content/10.1101/…
This represents how we believe haematopoiesis is actually proceeding at a clonal level. I'll walk through our preprint early next week. "A multi-track landscape of haematopoiesis informed by cellular barcoding and agent-based modelling" biorxiv.org/content/10.1101/…
New preprint.
Herein we describe a subset of CD8+ TILs highly enriched in Type I interferon signalling genes. These cells can be observed in various tumor entities but we first saw them in our dataset of treatment-naive HPV- HNSCC TILs.
biorxiv.org/content/10.1101/…
Many questions still remain, for example, how do these cells arise? What are the functional consequences on patient prognosis and tumour outcomes?
1
1
75
Big thanks to the patients whose contribution to science was invaluable and to the many co-authors, especially @theHumanBorch, Matthias Braun, and @Doc_Bald.
1
80











